 |
市場調査レポート
商品コード
1271076
多発性硬化症（MS）市場の規模と動向：疫学、疾患管理、パイプライン分析、競合評価、アンメットニーズ、臨床試験戦略、予測（～2030年）Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 多発性硬化症（MS）市場の規模と動向：疫学、疾患管理、パイプライン分析、競合評価、アンメットニーズ、臨床試験戦略、予測（～2030年） |
|
出版日: 2023年04月07日
発行: GlobalData
ページ情報: 英文 117 Pages
納期: 即納可能
|
- 全表示
- 概要
- 目次
当レポートでは、主要7市場の多発性硬化症（MS）市場について調査分析し、市場動向、パイプライン分析、競合情勢などを提供しています。
目次
第1章 多発性硬化症：エグゼクティブサマリー
第2章 イントロダクション
第3章 疾患の概要
第4章 疫学
第5章 疾病管理
第6章 競合評価
第7章 アンメットニーズと機会の評価
第8章 研究開発戦略
第9章 パイプラインの評価
第10章 パイプラインの評価の分析
第11章 現在と将来の企業
第12章 市場の見通し
第13章 付録
Abstract
The report provides an in-depth assessment of the MS market including disease overview, epidemiology, disease management, competitive assessment, unmet needs, R&D strategies, current and future players, and market outlook.
Multiple sclerosis (MS) is an autoimmune disease principally affecting the central nervous system. It causes nerve sheath demyelination followed by axon damage and paralysis with symptoms including muscle weakness, weak reflexes, tremor, muscle spasm, prolonged double vision, slurred speech, and lack of coordination or unsteady gait. Currently, there is no cure for MS. Most approved treatments address the inflammatory and systemic origins of the disease, but few possess neuroprotective effects, and, as such, have an insufficient impact on the underlying neurologic deterioration caused by MS. The primary goal of treatment with disease modifying therapies (DMTs) is to effectively manage disease activity by reducing the frequency of relapses and delaying the accrual of permanent disability. Of all MS subtypes, the treatment of relapsing-remitting MS remains the primary focus of the currently available DMTs.
Key Highlights
- Report deliverables include a Word report and an Excel-based forecast model
- Forecast includes the 7 major markets (7MM)
- Forecast covers the period 2020-2030
Scope
- Overview of MS, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized MS therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in ≥20 years old patient segments forecast from 2020 to 2030.
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for MS therapy. The most promising candidates in Phase III and IIb development are profiled.
- Analysis of the current and future market competition in the global MS therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the MS therapeutics market.
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global MS therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global MS therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
